Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT03626922
Title Study of Pembrolizumab With Pemetrexed and Oxaliplatin in Chemo-Refractory Metastatic Colorectal Cancer Patients
Recruitment Active, not recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors NSABP Foundation Inc
Indications

colorectal adenocarcinoma

Therapies

Folic Acid

Cyanocobalamin

Oxaliplatin + Pembrolizumab + Pemetrexed Disodium

Dexamethasone

Pembrolizumab + Pemetrexed Disodium

Age Groups: adult | senior
Covered Countries USA


No variant requirements are available.